Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03205176
Title Phase I Study of AZD5153 in Patients With Relapsed or Refractory Solid Tumors and Lymphomas
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca
Indications

Advanced Solid Tumor

ovarian serous carcinoma

lymphoma

Therapies

AZD5153

Age Groups: adult | senior
Covered Countries USA | CAN


No variant requirements are available.